|Rodman & Renshaw||Reni Benjamin|
|WBB Securities||Steve Brozak|
|Ladenburg Thalmann & Co||Kevin DeGeeter|
|JMP Securities||Charles Duncan|
|LifeTech Capital||Stephen Dunn|
|Morgan Joseph Triartisan||Raghuram Selvaraju|
Navidea Biopharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Navidea’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Navidea Biopharmaceuticals or its management. Navidea does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.